Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Postoperative Adjuvant Chemotherapy for Resectable Cholangiocarcinoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436681/all/Postoperative_adjuvant_chemotherapy_for_resectable_cholangiocarcinoma.
Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436681/all/Postoperative_adjuvant_chemotherapy_for_resectable_cholangiocarcinoma. Accessed March 24, 2025.
Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436681/all/Postoperative_adjuvant_chemotherapy_for_resectable_cholangiocarcinoma
Postoperative Adjuvant Chemotherapy for Resectable Cholangiocarcinoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436681/all/Postoperative_adjuvant_chemotherapy_for_resectable_cholangiocarcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma
ID - 436681
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436681/all/Postoperative_adjuvant_chemotherapy_for_resectable_cholangiocarcinoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -